November 2019 CPN by Community Pharmacy England

CPN

Community Pharmacy News â&#x20AC;&#x201C; November 2019

Pharmacy Representation Review

Professor of Pharmacy Practice to lead independent review into contractor support and representation Joint pharmacy manifesto | CPCS queries answered | Suppliersâ&#x20AC;&#x2122; Xmas opening

PSNC’S WORK

FUNDING AND STATISTICS

CONTRACT AND IT

Chief Executive’s blog This month PSNC Chief Executive Simon Dukes discusses the possibility of upcoming changes in both political and pharmacy representation.

Simon Dukes

PSNC Chief Executive As we approach the General Election on 12th December it continues to feel like a turbulent time in British politics: whatever Government we elect will face great challenges and must find a way to steer us through the ongoing Brexit situation. At our PSNC meeting in late November, we too were focused on what will be difficult and unpredictable times ahead as community pharmacies face significant financial and capacity challenges in the years to come. As the negotiator, PSNC accepted the five-year deal on the Community Pharmacy Contractual Framework (CPCF) this summer as the best outcome we believed was possible for the sector, recognising that the flat-cash funding would be incredibly challenging. We still believe that to have been the right decision – walking away risked further funding cuts, and we know that the NHS wants to unlock ‘major efficiency savings through the transformation and reform of dispensing – automation, online and supervision’. But as a sector we must now start to grapple with the very difficult question of how we deal with that funding squeeze.

“

There is a critical need to find new ways of working to release capacity

”

2 Community Pharmacy News – November 2019

As you would expect from your negotiator, we spent a considerable portion of our November meeting on those conversations. To say that we are very concerned about the financial and capacity pressures currently facing many community pharmacies is an understatement. There is a critical need for the sector to find new ways of working to find efficiencies and to release capacity. This does not mean trying to do what you have always done but faster or more efficiently; we know that pharmacists are working flat out as it is. Instead, it means thinking radically about your businesses and making fundamental changes to the way you work. This will be essential if the sector is to deliver all of the services set out in the five-year deal on the CPCF. The Committee spent time discussing the merits and issues with some of the different ways in which the sector might adapt in the years to come. This included looking at models of delivery, ways of working, prescribing trends and possible future legislation changes which could help contractors. There are no quick answers, and there will be much to return to when the Committee meets again in 2020. Independent Review of Support and Representation As many of you will know by now, Professor David Wright, Professor of Pharmacy Practice at the University of East Anglia, is to lead an independent review into the support and representation that PSNC and the LPCs collectively offer to contractors. This independent review comes at a critical time: as the sector comes under increasing financial pressure and enters a period of significant change, if not transformation, as part of the five-year CPCF. It is more important than ever that we and the LPCs serve contractors in the best possible way. Professor Wright will look to find ways for us to do that and I hope the review will

provide a sense check both for us and the LPCs, finding ways for us to work together even more effectively in the future to represent and support you through these changes. Although the review will of course draw on the views of both PSNC and the LPCs, it will be carried out independently by an experienced team of academics who have much knowledge of pharmacy, led by Professor Wright.

“

I hope the review will help PSNC and LPCs to work even more effectively in the future

”

Professor Wright has now launched his review and I would encourage all contractors to look at the website at: pharmacy-review.org. The website includes details of how to contact the review team and importantly about how independent contractors can take part in it. One option is to put yourself forward to be a member of the Steering Committee that will oversee the project and work being done by the team – you can do that by emailing Professor Wright a very short expression of interest. For others there will be many opportunities to participate including through focus groups and a national survey in 2020. I would encourage all contractors to engage with this review if they possibly can, even if only by completing the survey in due course – representing and supporting you locally and nationally has never been more important and it is only by sharing views on what you need and want for the future that we and the LPCs can make ourselves as fit for your futures as we possibly can be. See more about the review on the next page.

DISPENSING AND SUPPLY

SERVICES AND COMMISSIONING

THE HEALTHCARE LANDSCAPE

LPCS

Pharmacy representation review begins Professor David Wright will lead an independent review into PSNC and LPC representation and support for community pharmacy contractors. David Wright, Professor of Pharmacy Practice from the School of Pharmacy at the University of East Anglia, has been appointed to lead an independent review of the roles and structures underpinning PSNC and the LPCs. The review has been called at a time when the community pharmacy landscape is rapidly changing, and local representation and support has never been more important. It will be jointly funded by PSNC and the LPCs but carried out by Professor Wright and his team. The purpose of the review is to result in recommendations which will optimise PSNC and LPC contractor representation and support and ensure that the national network structure is working as efficiently for contractors as it can and is fit for the future. Professor Wright said: “I have been given a very short time frame but have a team in place who will work hard to ensure that we capture everyone’s voice and synthesize that into recommendations which move community pharmacy representation and support forward. I want to find out what is currently done well and how this could be done better and what is done which may be better done by others. I want to know whether the current organisational structures, financial models and communication processes provide greatest value for money and if they don’t, to explore how we can change them. I promise to ensure that the review is to be dispassionate, proportionate and focussed on delivery for contractors who are the paymasters.”

The review team is keen to hear from LPCs and contractors. The Steering Group will decide at its first meeting this year exactly how the review should engage with the sector, but it is expected that the team will be running a series of focus groups early in 2020 to be supported by a national survey and more in-depth interviews with some individuals. Further details will be shared in due course. For further information on the review, please visit: pharmacy-review.org

Getting involved A national steering committee is being set up to oversee the project and work with Professor Wright and his team and whilst most members will be nominated either by employer representatives or LPCs, David would like to include two independent contractors. Meetings will be in London, are planned to last for 2 hours from 1 to 3pm, with an attendance fee and travel expenses paid. With the dates set for December 19th, January 23rd, March 5th and April 2nd. Any independent contractors who are not currently on an LPC and are interested in joining the national steering committee are invited to send David Wright an expression of interest in no more than 50 words to d.j.wright@uea.ac.uk.

General Election campaigning The National Pharmacy Association (NPA), Royal Pharmaceutical Society (RPS) and PSNC have created resources to help promote community pharmacy ahead of the General Election on 12th December. The upcoming election presents a great opportunity for the sector to be recognised as a valuable health and wellbeing asset, and a solution to many longstanding problems in the NHS. To help make these messages clear to all candidates standing in the election, the pharmacy organisations have created a shared ‘pharmacy manifesto’, which sets out how we hope any new Government will commit to investing in the sector. This joint manifesto is available in our General Election Hub and may be a useful document for any LPCs or contractors who are engaging with parliamentary candidates in the lead up to the 2019 General Election. The General Election Hub also contains some additional guidance from PSNC for LPCs and contractors hosting pharmacy visits with candidates in the coming weeks. This includes some tips on content and key messages, as well as a template invitation and press release. Find our General Election Hub at: votepharmacy.uk

psnc.org.uk 3

SERVICES AND COMMISSIONING

THE HEALTHCARE LANDSCAPE

LPCS

CPCF payment dates Community pharmacy contractors are reminded of the dates and details of new payments. With the changes implemented with the new five-year Community Pharmacy Contractual Framework (CPCF), community pharmacy contractors should be aware of the changes to existing payments and new payments that will appear (subject to claiming) in your Schedule of Payments. These changes are described in the table below. Payment type

Sign-up deadline

Payment date

Payment amount

How will payment appear on the Schedule of Payments under section of ‘Details of other amounts authorised’

Aspiration payment

11:59pm on 1st November 2019

29th November 2019

Dependent on points claimed for 2018/19 Quality Payments Scheme

‘Pharmacy Quality Scheme’

Establishment payment

N/A

31st December 2019

Dependent on number of items dispensed monthly

‘Establishment payment’

Transitional Payments

N/A

31st December 2019

Dependent on number of items dispensed monthly

‘Transitional payment’

Supplement to transitional payment* (CPCS sign-up fee)

1. 31st October 2019 2. 1st December 2019 3. 15th January 2020

1. 31st December 2019 2. 31st January 2020 3. 28th February 2020

1. £900 2. £900 3. £600

‘CPCS Sign-up Fee’

CPCS payment

N/A

First CPCS payment claimed in October or November 2019 will appear in 31st January 2020 Schedule of Payments

Fee of £14

‘CPCS Remuneration payment’ ‘CPCS Reimbursement Payment’

SSP payments

N/A

31st December 2019

£5.35 fee per SSP claim

‘SSP Remuneration (SSP fees)’ ‘SSP Reimbursement (VAT element only)’

*The supplement to the transitional payment has three deadlines. Payments will differ based on which deadline has been met.

Pharmacy Quality Scheme (PQS): New guidance issued SCR quality criterion

NSAID quality criterion

Criterion: Contractors must demonstrate access to the Summary Care Record (SCR) between 1st October 2019 and the day of their declaration (in February 2020).

Criterion: Contractors must implement the recommendations from the previous clinical audit on NSAIDs prescribed for those aged 65 years and above without gastroprotection, and then repeat the updated audit.

Guidance: PSNC recommends using NHS Digital’s spreadsheet of SCR viewing figures for community pharmacy. Contractors can also access a data visualisation tool to view their weekly SCR viewing figures. The spreadsheet will be updated each Thursday to show the previous week’s data. Contractors are advised to keep a screenshot of any SCR access recorded in the spreadsheet for validation purposes.

Guidance: Resources have now been published, so contractors may want to consider when they are going to start completing the audit. Contractors can pick any two-week period before the PQS declaration but are reminded that the data collection period may need to be extended to four weeks if they have difficulty finding ten patients to participate.

Further support can be found at: psnc.org.uk/pqsscr

Further support can be found at: psnc.org.uk/pqsnsaid

4 Community Pharmacy News – November 2019

Risk management and safety domain Criteria: Two of the five quality criteria for this domain are to undertake a risk review and produce a new patient safety report. Guidance: PSNC and the Community Pharmacy Patient Safety Group have produced guidance which provides information on what contractors need to do to meet these quality criteria. These documents also contain worked examples of the risk review templates, as well as worked examples of the monthly and annual patient safety report template. Further support can be found at: psnc.org.uk/pqsriskreview and psnc.org.uk/pqspatientsafetyreport

PSNC’S WORK

FUNDING AND STATISTICS

CONTRACT AND IT

DISPENSING AND SUPPLY

CPCS Frequently Asked Questions With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the service which PSNC has been asked over the last few weeks. Q. I have received an urgent medicine supply referral for a patient, however their GP practice is still open. What is the best way to proceed?

Q. Will there be a training programme for CPCS? As announced in the five-year contractual agreement, NHS England and NHS Improvement (NHSE&I) and Health Education England (HEE) will use funding (c. £2m) from the Pharmacy Integration Fund to commission continuing professional development (CPD) sessions for pharmacists related to the CPCS. This training will build on the CPD already delivered in the Digital Minor Illness Referral Service (DMIRS) pilot areas. While it is not mandatory to undertake, PSNC recommends that pharmacists do participate in the training in 2020/21, as it will help them to undertake effective consultations, communications and clinical assessments. The CPD sessions will have a particular focus on identifying red flags, referring appropriately to the wider NHS network, if needed and effective patient follow-up. Q. I want to undertake the CPCS CPD training in 2019/20 but I haven’t been able to get a place on a training course. Will I miss out on this completely? No. The Centre for Pharmacy Postgraduate Education (CPPE) is running some training across England this year, which builds on the programme they ran in the DMIRS pilot areas. This training is the forerunner to a major roll out of training in 2020/21. HEE is currently procuring this programme (November 2019) with funding from the Pharmacy Integration Fund. This training will be made available to all pharmacists that want to access it in 2020/21. Q. A patient has contacted the pharmacy and said they had been referred for the CPCS, but there is no referral email or message in the CPCS IT system. How do I proceed? The pharmacist should check with the patient the name of the pharmacy that they were referred to. If the patient has been referred to the correct pharmacy, the pharmacist should check again for a referral message. If no email or referral message is found, the pharmacist should contact the referring service, e.g. calling the NHS 111 Health Professionals Line (this number should be included in your SOP). This should be recorded in the pharmacy and reported to the referring service provider as an incident.

Patients should be advised to contact the GP practice if this is practically the most appropriate option to obtain their medicine or appliance. This may not be possible if, for example, the patient is away from home and unable to access their GP practice or where the GP practice will not be able to issue a prescription in a timely manner, such that the patient can get that prescription dispensed in time for their next required dose of the medicine. The pharmacist will need to assess each individual request and the circumstances of the patient to determine whether it is appropriate to make a supply via the CPCS.

Q. I have received a referral that says the patient needs to see a GP within 72 hours. Is this an incorrect referral from NHS 111? Generally, no. The disposition names used in Directory of Services (DoS) and the NHS Pathways system can sometimes look like they are not appropriate referrals to community pharmacy, but despite some of the names/descriptors, they have all been clinically assessed as being appropriate for referral to and management in community pharmacy. Pharmacists should therefore deal with these CPCS referrals as they would any others. Where a pharmacist believes an inappropriate referral has been made, this should be reported via the incident report form which can be found in Sonar and PharmOutcomes.

Key learnings and tips on CPCS Further information is available in two new briefings for pharmacy contractors and LPCs. These briefings are based on some of these questions and on early feedback and learnings about the service from contractors and LPCs. Find the guidance at: psnc.org.uk/CPCS

psnc.org.uk 5

SERVICES AND COMMISSIONING

THE HEALTHCARE LANDSCAPE

LPCS

Flu Vaccination Service updates As the 2019/20 flu vaccination season progresses, community pharmacy teams have been provided with further information and support for a successful service. Despite the majority of community pharmacy teams now being well versed in how to run a successful Flu Vaccination Service, new issues can arise. Here are some recent notices to be aware of. Transferring QIV vaccines The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that that due to the current supply issues with quadrivalent influenza vaccines (QIV), it would not prevent the transfer of these vaccines between providers. This could apply, for example, from a community pharmacy to a GP practice or vice versa. This notice applies to both the egg-grown quadrivalent influenza vaccine (QIVe) and the newly licenced cell-based quadrivalent influenza vaccine (QIVc). The MHRA has advised that for this transfer to be allowed the following conditions must be met:

• the practice, pharmacy or NHS Trust that is holding the excess QIV stock has assurance that the vaccine has been stored in the correct temperaturecontrolled conditions; • confirmed record keeping of temperature monitoring is available; • the practice, pharmacy or NHS Trust that requests QIV is able to verify the assurances given; and • the vaccine can be transported appropriately under the right cold chain conditions. The NHSE&I letter can be viewed at: ow.ly/TjU730pU4qm People with learning disabilities Around 1 in 3 deaths of people with a learning disability are caused by respiratory problems and the number of respiratory related deaths increases during winter. Having the flu jab can help avoid preventable deaths for people with a

learning disability during this period. This cohort is eligible for an NHS flu vaccination under the Community Pharmacy Flu Vaccination Advanced Service, as learning disabilities are categorised as a neurological condition. PSNC has suggested some actions to assist pharmacy teams in improving uptake of flu vaccinations for people with learning disabilities: ow.ly/mzFl30pU4t9 Identifying carers and care workers Carers and employed care workers who are aged 18 years or over are also eligible to receive a flu vaccination in a community pharmacy, but it can be difficult to identify these groups. PSNC has highlighted some resources to assist pharmacy teams in identifying carers and care workers who may be eligible for a flu vaccination: ow.ly/qjLD30pU4qJ

Depression Optimise course Develop your skills and confidence in engaging with people who have depression with the Centre for Pharmacy Postgraduate Education (CPPE)’s latest programme. At least a third of the English population is “predicted to experience an episode of mild depression during their lifetime, so it is likely that someone you know or care about will be affected by depression. However, unlike physical ill heath, the symptoms of depression are often invisible. Social stigmas around Sneha Varia depression can often inhibit people from Regional Manager, East of England, talking about their condition or seeking help, CPPE with almost 40% of people who meet the criteria for major depression not going to see their doctor. Are you confident talking to people with depression about their condition? Our new Depression Optimise programme aims to help you to improve your consultation skills with people who have depression and gain confidence in engaging in discussions. This

6 Community Pharmacy News – November 2019

programme also aims to develop your ability to listen to the person’s concerns and respond to their needs. Completing our Depression Optimise programme will help you to be able to summarise the risks and benefits of antidepressants and undertake discussions about treatment options with people with depression that meet their needs. Our Optimise programmes are designed so that any member of your team can run a small group learning session. The learning consists of preparation activities (20 minutes) on medicines optimisation followed by the learning session (40 minutes) which includes clinical decision making. Learn more about the Depression Optimise programme at: www.cppe.ac.uk/programmes/l/depress-o-01

”

PSNC’S WORK

FUNDING AND STATISTICS

CONTRACT AND IT

DISPENSING AND SUPPLY

Pharmacy notice board In this section of Community Pharmacy News we have highlighted some key notices for you and your team to be aware of in the coming weeks and months.

EPS Phase 4 rollout

EPS Phase 4 has begun rolling out to more GP practic es using the TPP SystmOne GP system. All community pharma cy teams should therefore be aware that they may receive EPS Phase 4 tokens to process. Full rollout for TPP SystmOne GP system practic es will take place in the coming weeks and months on a location by location basis. Areas going live this year include parts of London, Gloucestershire and Greater Huddersfield. PSNC recommends refreshing your EPS Phase 4 knowledge at: psnc.o rg.uk/E PSphas e4

Start of the Help Us Help You campaign are Community pharmacy contractors campaign You Help Us Help the that ded remin runs from 11th November until 31st December 2019, so they should therefore ensure they are displaying the related promotional materials as part of this public health campaign.

kSv Find out more at: ow.ly /IHu7 30pS

PSNC Medicine shortages reporting form Medicine shortages are becoming an increasingly frequent issue that can hinder pharmacy teams’ efforts to dispense medicines in a timely manner. PSNC is very concerned about the impact that current supply problems are having on pharmacy teams’ workload and about the potential impact on their patients. Pharmacy teams can report any new medicine shortages not listed on the Specialist Pharmacy Service (SPS) website using our online reporting form: psnc.org .uk/repo rtshorta ge

Priority Services Register

er to boost their sign up for the Priority Services Regist Community pharmacy contractors can business continuity arrangements. acy has priority on this register should mean your pharm Run by the UK’s utility companies, inclusion s. access to electricity, water and gas supplie p and provide contact details. Your utility bills may explain how to sign-u ity Service “Prior Alternatively, search for “PSR” and or tes. websi any Register” on your utility comp Find out more at: ow.ly/ QAby 30pV z8I

psnc.org.uk 7

DISPENSING AND SUPPLY

22 lines added to DND list Following representation from PSNC, 22 new products entered the Drugs for which Discount is Not Deducted (DND) list (Part II of the Drug Tariff) from November. The assumed level of discount normally applied when community pharmacy contractors dispense medicines and appliances will no longer be applied to products such as Adempas tablets, Cialis 5mg tablets, Esbriet tablets, Melatonin 1mg/ml oral solution sugar free and Toctino capsules. View the full list at: ow.ly/KoZy30pVyFh PSNC will continue to monitor lines that may meet DND entry criteria and welcome reports from contractors for products that meet the necessary criteria.

Parallel export ban update Additions have been made to the list of medicines which must not be parallel exported from the UK. These include: • Algoliptin/metformin • Measles, Mumps and Rubella vaccine • Misoprostol • Pneumococcal Polysaccharide vaccine • Hepatitis A and B vaccine The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) have added these products to the list to ensure their continued supply to meet the needs of UK patients. The full list can be viewed at: ow.ly/jXwU30pVyDG

When to endorse NCSO The NCSO endorsement should only be used where supply has been made against a valid Serious Shortage Protocol (SSP). NCSO should not be used for nonSSP items. The last No Cheaper Stock Obtainable (NCSO) status was granted in April 2013 and ‘NCSO’ is not a valid endorsement for a price concession. If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC for investigation: psnc.org.uk/concessions

8 Community Pharmacy News – November 2019

SERVICES AND COMMISSIONING

THE HEALTHCARE LANDSCAPE

Serious Shortage Protocol update Further extension and amendment to the Fluoxetine 30mg capsules SSP, whilst SSPs for other strengths come to an end.

“

Fluoxetine 30mg capsules is the only remaining SSP, but with an important amendment

”

The Department of Health and Social Care (DHSC) has further extended the Fluoxetine 30mg capsules Serious Shortage Protocol (SSP), but with a change to the alternative product. Before issuing an SSP, the pharmacist should always check the up-to-date protocol. SSP02 for Fluoxetine 30mg capsules: This has been further extended with a revised expiry date now set as 18th December 2019. An amendment to the SSP also means that pharmacists who decide it is appropriate to follow the protocol must now supply Fluoxetine 10mg capsules instead of tablets – i.e. for every Fluoxetine 30mg capsule supply 1 x Fluoxetine 10mg capsule, plus 1 x Fluoxetine 20mg capsule. Fluoxetine 10mg tablets can no longer be supplied against SSP02 after the 20th November. SSP03 Fluoxetine 40mg capsules: This SSP expired at the end of Wednesday 20th November 2019. Sufficient stock is now available to supply normal demand for dispensing against prescriptions for Fluoxetine 40mg capsules. SSP03 is therefore no longer valid for use and any prescriptions presented for Fluoxetine 40mg must be dispensed in accordance with the original prescription. SSP01 Fluoxetine 10mg capsules: This SSP expired at the end of 25th October 2019 so it is no longer be valid for use. The Secretary of State authorised three SSPs in early October to help manage the supply of some formulations of Fluoxetine. These SSPs were put in place to manage stock and to try to ensure that fewer patients have to return to their prescriber.

Top Tips • View our SSP submission reminder to ensure your SSP claims are appropriately submitted to the NHS Business Services Authority (NHSBSA) for reimbursement: ow.ly/oS3v30pVyqF • Pharmacy teams are advised to submit SSP claims using the EPS token if your PMR system does not support/capture all the SSP endorsement required. • Any paper prescriptions or tokens with SSP claims need to be placed in a red separator (and kept separate from other tokens for non-payment i.e. with paid/ exempt status). • SSPs will be accepted for up to three calendar months after expiry or withdrawal of the SSP. • Current versions of SSPs can be found at: psnc.org.uk/liveSSPs • For more information on endorsing SSPs see psnc.org.uk/SSPfactsheet

LPCS

PSNC’S WORK

FUNDING AND STATISTICS

CONTRACT AND IT

Ask PSNC The PSNC Dispensing and Supply Team answers your recent queries on the Drug Tariff and reimbursement. Q. I have a prescription for ‘Phenelzine sulfate 15mg tablets’, I am only able to obtain an unlicensed special, will I be paid for it? A. No. The prescription must state ‘Phenelzine sulfate 15mg tablets (Special Order)’ to ensure community pharmacy contractors are paid for an unlicensed special. For EPS prescriptions the prescriber must select the ‘Special Order’ listing, additional information free typed in the prescribing area cannot be viewed by the NHS Business Services Authority (NHSBSA) and you would be reimbursed the Drug Tariff list price. If the prescription states ‘Special Order’ in the prescribing line, the usual unlicensed special endorsements are required. Contractors are also reminded that all prescriptions for unlicensed medicines should be placed in the red separators for your end of month submission. For more information on unlicensed specials and imports, see psnc.org.uk/unlicensed. Q. Are appliances eligible to be added to the DND list? A. Under the current arrangements, the only appliance included in the Discount Not Deducted (DND) list is the FreeStyle Libre Sensor. Previously, the Department of Health and Social Care had indicated to PSNC that appliances were not in scope of the criteria for inclusion to the DND list. PSNC strongly believes that where discount is not available when purchasing an appliance, to ensure patient access and continuity in care, the product should be eligible for exemption from discount deduction. Under the old discount deduction arrangements, made-tomeasure elastic hosiery and trusses were included in the ‘Zero

Discount’ list but these products were removed from the list in September 2006. In 2005, the DHSC carried out a consultation on the arrangements for the supply of appliances to primary care. In the response, PSNC highlighted the fact that NHS pharmacy contractors are not contractually obliged to supply appliances which are not supplied in the normal course of their business. For more information on how discount deduction works, see psnc.org.uk/dnd Q. Do I need to submit age exempt EPS tokens with my end of month bundle? A. No, contractors should not submit age exempt Electronic Prescription Service (EPS) tokens with their end of month prescription bundles. The tokens which should be sent to the NHSBSA are those where: • the exemption status has been captured (other than were the patient is age exempt, i.e. aged under 16 or 60 or over); or • if the patient has paid a charge. Pharmacy teams are reminded that tokens are submitted for audit purposes only and not used for payment. Reimbursement is made against electronically submitted claim messages and the exemption category applied to that message. Tokens which do not need to be sent to the NHSBSA can be disposed of in accordance with the Data Protection Act and the pharmacy team’s own processes. For more information on submitting EPS tokens see psnc.org.uk/epstokensubmission

Can it be dispensed on an FP10? Product

Is the item listed in the Drug Tariff?

Is it Does it Can it be in the have a ‘CE’ dispensed blacklist?* mark? on an FP10?

Additional information

ClearWay bridge 7700 30 device

Yes

n/a

Yes

This item is a medical device (CE marked) and is listed in Part IX of the Drug Tariff.

Nipple Shield plastic

Yes

n/a

Yes

This item is a medical device (CE marked) and is listed in Part IX of the Drug Tariff.

SoftPads skin protector

Yes

n/a

Yes

This item is a medical device (CE marked) and is listed in Part IX of the Drug Tariff.

Attends Cover Dri Super incontinence pad

n/a

Yes

This item is a medical device (CE marked) and is not listed in Part IX of the Drug Tariff.

*n/a is because medical devices are not listed in the blacklist.

psnc.org.uk 9

DISPENSING AND SUPPLY

SERVICES AND COMMISSIONING

THE HEALTHCARE LANDSCAPE

Drug Tariff Watch The Preface lists additions, deletions and alterations to the Drug Tariff. Below is a quick summary of the changes due to take place from 1st December 2019. Part VIIIA additions Category C: • Dipyridamole 200mg modified-release / Aspirin 25mg capsules (60) – Molita • Measles, Mumps and Rubella vaccine (live) powder and solvent for suspension for injection 0.5ml pre-filled syringes (1) – M-M-RVAXPRO Part VIIIA amendments • Co-dydramol 20mg/500mg tablets (112) – Remedeine is changing to Category A • Co-dydramol 30mg/500mg tablets (56) – Remedeine Forte is changing to Category A • Colestyramine 4g oral powder sachets sugar free (50) – Questran Light is changing to Category A

KEY:  Special container  Item requiring reconstitution * This pack only (others already available)

• Ethinylestradiol 35microgram / Norgestimate 250microgram tablets (63) – Cilest is changing to Cilique • Sevelamer 2.4g oral powder sachets sugar free (60) Category A is changing to Renvela Part VIIIA deletions • Bisoprolol 10mg / Aspirin 100mg capsules (30) – Aspire Pharma Ltd • Bisoprolol 10mg / Aspirin 75mg capsules (30) – Aspire Pharma Ltd • Bisoprolol 5mg / Aspirin 100mg capsules (30) – Aspire Pharma Ltd • Bisoprolol 5mg / Aspirin 75mg capsules (30) – Aspire Pharma Ltd • Mesalazine 250mg suppositories (20) – Asacol • Orange tincture BP 2001 (100ml) – J M Loveridge Ltd • Salicylic acid 11% / Lactic acid 4% gel (5g) – Cuplex Verruca

Part IX deletions It is important to take careful note of removals from Part IX because if you dispense a deleted product, prescriptions will be returned as disallowed and therefore payment will not be made for dispensing the item. Product BANDAGES – Multi-layer Compression Bandaging – Jobst Comprifore bandage kit BANDAGES – Multi-layer Compression Bandaging – Jobst Comprifore Latex-free bandage kit BANDAGES – Multi-layer Compression Bandaging – Jobst Comprifore Lite bandage kit BANDAGES – Multi-layer Compression Bandaging – Jobst Comprifore Lite Latex-free bandage kit DRESSINGS – WOUND MANAGEMENT DRESSINGS – Wound Dressing Pack – Pico DRESSINGS – WOUND MANAGEMENT DRESSINGS – Wound Dressing Pack – Pico Multisite STOCKINETTE – Elasticated Viscose Stockinette, Bandage (Lightwight Ealsticated Viscose Tubular Bandage) – Coverflex LEG BAGS – Simpla Trident T1 with slide action tap LEG BAGS – Simpla Trident T2 with slide action tap

COLOSTOMY BAGS – Hollister Ltd – Impression “C” with convex wafer, Transparent front with filter and beige Comfort backing on body worn side ILEOSTOMY (DRAINABLE) BAGS – Hollister Ltd – Karaya 5 seal 30.5cm Length, Transparent CHEMICAL REAGENTS – DETECTION STRIPS, BLOOD FOR GLUCOSE – Biosensor Strips – iHealth CHEMICAL REAGENTS – Colorimetric Strips – Compact

Additional information (e.g. size, product code, etc.) All sizes All sizes All sizes All sizes All sizes All sizes All sizes All types 500ml bag short tube (376138), 500ml bag long tube (376139), 750ml bag long tube (376142) 35mm (3595) 76mm (3226) 50 3 drums of 17 strips each

PSNC website For up to date information and news on community pharmacy issues, visit the PSNC website at psnc.org.uk PSNC Community Pharmacy News is published by: The Pharmaceutical Services Negotiating Committee, 14 Hosier Lane, London, EC1A 9LQ Community Pharmacy News is edited by: Melinda Mabbutt who can be contacted at the above address or by email at: mmabbutt@psnc.org.uk PSNC Office: 0203 122 0810

Normal hours

08:45–16:45

Normal hours

08:00–16:00

08:00–14:00

08:30–16:00

Normal hours

TBC

Normal hours

TBC

Kyowa Kirin

Lundbeck

Movianto

Novartis

Novo Nordisk

Phoenix

Pfizer

Roche

Sanofi

Sigma

Bank Holiday

Closed

TBC

Normal hours

TBC

Normal hours

08:30–18:00

08:00–17:30

09:00–16:00

Normal hours

Closed

09:00–17:00

09:30–19:00

09:00–16:00

08:30–16:30

TBC

Fri 27th Dec

For the latest information and order cut off/delivery schedules, please visit: ow.ly/5jEA30pXyZK

Bank Holiday

09:00–15:00

Eli Lilly

Bank Holiday

Closed from midday

09:30–15:30

DE Pharma

Bank Holiday

Wockhardt

09:00–16:30

BoehringerIngelheim

Bank Holiday

08:30–16:30

Amgen

Bank Holiday

Thurs 26th Dec

Closed

TBC

Normal hours

TBC

Normal hours

08:30–18:00

08:00–17:30

09:00–16:00

Normal hours

Closed

09:00–17:00

09:30–19:00

09:00–16:00

08:30–16:30

TBC

Mon 30th Dec

Closed

TBC

Normal hours

TBC

Normal hours

08:30–16:00

08:00–14:00

08:30–16:00

Normal hours

Closed

09:00–15:00

09:30–15:30

09:00–16:00

08:30–16:30

TBC

Tues 31st Dec

Bank Holiday

Mon 1st Jan

Normal hours

Closed

TBC

Normal hours

TBC

Normal hours

08:30–18:00

08:00–17:30

Normal hours

08:30–16:30

TBC

Tues 2nd Jan

FUNDING AND STATISTICS

Closed

TBC

Alliance

Bank Holiday

Weds 25th Dec

PSNC’S WORK

Waymade

TBC

AAH

Tue 24th Dec

A summary of customer service desk opening hours for the Christmas period.

Manufacturer & Wholesaler Christmas Opening Hours 2019 LPCS CONTRACT AND IT

psnc.org.uk 11